Protecting the environment

We are focused on reducing our GHG emissions and managing our energy use more efficiently. That is why we put a target in place to reduce our Scope 1 and 2 emissions by 25% by 2030, compared to a 2020 baseline. As of 2023, we've achieved a 15% reduction in our Scope 1 and 2 emissions, totalling 123,727 tonnes of CO2 equivalent. Read our sustainability report for the latest status update of our progress.

We are continuously improving our use of water and treatment of waste. As water use is an essential component of the pharmaceutical manufacturing process, and based on our geographical footprint and presence in water stressed locations, we continue to assess sites where we have determined water security issues to be most material.

We are committed to sustainable practices across our supply chain. Our Supplier Code of Conduct safeguards standards that we regard as essential and fundamental, including protecting human rights and ethical conduct, preventing modern slavery and addressing environmental issues. To improve our understanding of the sustainability maturity of our supply chain and manage any related risks, we use the services of a third party sustainability ratings agency.

We are aligning our internal processes and our public disclosures with the TCFD recommendations. Our latest progress update can be found in our Annual Report. Through our enterprise risk management framework we assessed relevant climate-related risks and opportunities. These include the impact of severe weather events and the impact of chronic changes to the natural environment, as well as transition risks such as impact of carbon pricing and energy pricing.